WILMINGTON, MA – Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced hiring four additional sales and marketing managers, as well as the establishment of a specialized Government Marketing and Sales team aimed at serving the needs of domestic homeland security in the U.S.

Implant Sciences projects that the global explosives trace detection market will grow to approximately $1 billion by 2014. A study by IMS research estimates that 42% of that market is in the U.S. To date, Implant Sciences has had increasing traction with international sales through its growing global distribution network.

“The expansion of our sales and marketing team over the past 12 months has directly resulted in significant sales increases, primarily from international markets,” stated Implant Sciences CEO, Glenn Bolduc. “With the addition of these four talented sales and marketing individuals, we aim to further increase revenue growth through domestic U.S. sales to government and private industry.”

Implant Sciences’ newly formed Government Marketing and Sales team consists of Marc Gregorio, Director of Federal Business Development, and Jessica Tocco, Government Marketing Manager.

Marc Gregorio was recently Director of Government Markets for the Security & Detection Systems Division of L-3 Communications, a major defense contractor and government services provider. With L-3, Marc focused on key customers at the Departments of Homeland Security, Justice, State, and Defense. Prior to L-3, he was Director of Federal Sales at Rapiscan Systems, a leading provider of security inspection systems. He has held executive level sales, marketing, and operations positions with several other companies in the electronic security, non-intrusive inspection and explosives trace detection market.

Jessica Tocco has deep experience in commerce and government. She started her career as an Intern at The White House, working directly for Karl Rove, the Senior Advisor to the President. She was then Confidential Assistant to Carlos Gutierrez, the Secretary of the United States Department of Commerce. Prior to joining Implant Sciences, she was Director of the American Chamber of Commerce in Vietnam and the Director of the Asia Pacific Council of American Chambers.

Kelly Wennik, a successful sales professional with more 20 years of marketing, sales and business development experience working with top-tier Fortune 100 companies, joins Implant Sciences as Managing Director of the Americas. She will be responsible for all countries in North and South America, including U.S. sales, excluding federal government. Before joining Implant Sciences, Ms. Wennik was a Vice President with MORPACE, delivering industry relevant analysis and consulting services. Prior to that, she was Director, Client Development with Harris Interactive and Business Development Manager for Leading Indicator Systems.

David Spada rounds out the newly hired team as Product Manager. In this role, he will guide the development of new products that support the Company’s growth strategy. Mr. Spada has a Master of Science in Engineering Management from Tufts University, as well as a Bachelor of Science in Electrical and Computer Engineering from Northeastern University. He was formerly Product Manager at Aspect Software for advanced voice technology products. Previously, he was a Business Development and Product Manager at Analogic Corporation for medical products.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences’ QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain “forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management’s current expectations and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management’s current expectations and assumptions which could differ materially from the forward-looking statements.